GlassScriptPhysician profile
Eric Mcqueary
NPI 1609215003
$9,157.30
in general payments reported to CMS, 2019-2025
48 companies · $1,796 in 2025
The $1,796 reported for 2025 was more than what 77% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $617 · 2020: $613 · 2021: $1,448 · 2022: $1,450 · 2023: $1,915 · 2024: $1,318 · 2025: $1,796.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,871 · Education: $159.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,870.66 |
| Education | $159.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $1,134.63 | 2019-2024 | Xtandi, Myrbetriq |
| Janssen Biotech, INC. | $1,017.48 | 2019-2025 | Erleada, Akeega, Balversa |
| Sumitomo Pharma America, INC. | $823.58 | 2023-2025 | Gemtesa, Orgovyx |
| Dendreon Pharmaceuticals LLC | $538.06 | 2021-2025 | Provenge |
| Pfizer INC. | $517.47 | 2019-2025 | |
| Amgen INC. | $447.60 | 2019-2025 | Prolia, Prolia, Xgeva |
| Medtronic, INC. | $392.58 | 2021-2025 | Interstim |
| Kowa Pharmaceuticals America, INC. | $353.91 | 2022-2023 | Seglentis |
| Bayer Healthcare Pharmaceuticals INC. | $334.33 | 2019-2025 | |
| Teleflex LLC | $322.95 | 2021-2025 | Urolift, Barrigel |
| 180 Medical, INC. | $309.92 | 2020-2025 | Gentlecath, Speedicath |
| Merck Sharp & Dohme LLC | $300.18 | 2020-2025 | Keytruda, Lynparza, Keytruda Qlex |
| Calyxo, INC. | $222.34 | 2025 | Cvac Aspiration System |
| Urovant Sciences INC | $204.51 | 2021-2022 | |
| Boston Scientific Corporation | $203.93 | 2019-2025 | Bulkamid, Lithovue, Rezum Generator |
Show all 48 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eric Mcqueary listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.